Biolife Solutions Income Statement (2010-2025) | BLFS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	16.85M	31.20M	33.80M	37.30M	36.22M	40.53M	40.75M	-41.26M	37.70M	29.24M	23.57M	-13.98M	18.43M	19.71M	21.39M	15.11M	23.94M	25.42M	28.07M	18.79M
Cost of Revenue (Quarter)	2.02M	3.14M	4.07M	4.78M	4.89M	5.42M	5.28M	-3.93M	6.47M	3.83M	4.88M	-1.35M	2.38M	2.48M	2.51M	17.18M	2.60M	2.73M	2.53M	1.99M
Gross Profit (Quarter)	14.83M	28.06M	29.73M	32.53M	31.33M	35.12M	35.47M	-37.33M	31.23M	25.41M	18.70M	-12.62M	16.06M	17.23M	18.88M	-2.08M	21.34M	22.69M	25.54M	16.79M
Operating items
Amortization - Intangibles (Quarter)	0.93M	1.88M	2.52M	2.90M	2.90M	2.86M	2.50M	-4.20M	1.46M	1.40M	1.31M	-3.07M	0.70M	0.68M	0.68M	-1.79M	0.70M	0.71M	0.70M	-1.84M
Research & Development (Quarter)	1.99M	3.04M	3.22M	3.57M	3.78M	3.43M	3.42M	-1.96M	4.15M	3.79M	3.74M	-5.26M	2.08M	2.03M	1.89M	-1.25M	2.20M	2.72M	2.71M	-0.07M
Selling, General & Administrative (Quarter)	4.83M	7.15M	10.08M	11.61M	11.53M	11.65M	11.92M	-1.84M	14.84M	13.54M	10.81M	5.22M	10.40M	9.32M	9.33M	11.59M	11.50M	11.40M	12.07M	10.55M
Restructuring Costs (Quarter)	1.00M	0.27M	0.34M	0.02M	0.01M	0.01M	0.00M						0.24M
Other Operating Expenses (Quarter)	-1.92M	7.08M	0.08M	-14.47M	28.86M	102.01M	37.15M	-127.80M	32.31M	22.53M	24.50M	-58.17M	9.02M	9.67M	10.59M	-20.32M	11.45M	27.95M	13.37M	-27.14M
Operating Expenses (Quarter)	17.83M	35.76M	44.96M	55.77M	44.19M	117.10M	52.49M	-131.61M	51.31M	39.87M	39.05M	-58.20M	21.73M	21.02M	21.81M	-9.98M	25.16M	42.06M	28.16M	-16.66M
Operating Income (Quarter)	-0.98M	-4.55M	-11.16M	-18.46M	-7.97M	-76.56M	-11.74M	90.35M	-13.61M	-10.63M	-15.47M	17.53M	-3.29M	-1.31M	-0.42M	0.54M	-1.22M	-16.64M	-0.09M	1.35M
EBIT (Quarter)	-0.98M	-4.55M	-11.16M	-18.46M	-7.97M	-76.56M	-11.74M	90.35M	-13.61M	-10.63M	-15.47M	17.53M	-3.29M	-1.31M	-0.42M	0.54M	-1.22M	-16.64M	-0.09M	1.35M
Non-operating items
Non Operating Investment Income (Quarter)					-0.18M		0.70M		-0.41M					-4.07M
Interest & Investment Income (Quarter)	-0.02M	-0.12M	-0.19M	-0.15M	-0.16M	-0.03M	-0.01M	-0.03M	-0.41M	-0.39M	-0.45M	-0.19M	-0.14M	-0.33M	-0.23M	-0.07M	0.68M	0.68M	0.51M	0.83M
Other Non Operating Income (Quarter)			-0.01M	0.30M	0.13M	-0.02M	0.14M	0.39M	0.39M	0.38M	0.23M	0.27M	0.25M	0.15M	0.10M	-0.00M	0.10M	0.25M	0.28M	1.18M
Non Operating Income (Quarter)	-0.14M		-0.01M	-5.70M	-0.05M	-0.02M	0.82M	0.39M	0.39M	0.38M	-0.21M	0.08M	0.25M	-4.25M	0.10M	-0.07M	0.78M	0.93M	0.79M	3.89M
Net income details
EBT (Quarter)	-1.12M	-4.68M	-4.91M	-18.32M	-8.02M	-76.62M	-10.92M	90.70M	-13.62M	-5.52M	-15.69M	17.61M	-3.18M	-5.56M	-0.55M	0.47M	-0.43M	-15.71M	0.70M	3.36M
Tax Provisions (Quarter)		-12.55M	-4.99M	-2.58M	-0.60M	-3.74M	-0.60M	-0.30M	0.09M	0.00M	0.12M	-0.27M	0.02M	0.00M	-0.08M	0.02M	0.01M	0.13M	0.08M	-0.15M
Profit After Tax (Quarter)	-1.12M	7.88M	0.08M	-15.74M	-7.42M	-72.88M	-10.32M	91.00M	-13.71M	-5.52M	-15.80M	40.89M	-10.22M	-5.56M	-1.70M	23.86M	-0.45M	-15.84M	0.62M	11.07M
Equity Income (Quarter)
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)	-1.12M	7.88M	0.08M	-15.74M	-7.42M	-72.88M	-10.32M	91.00M	-13.71M	-5.52M	-15.80M	17.89M	-3.20M	-5.56M	-0.47M	0.45M	-0.45M	-15.84M	0.62M	3.51M
Consolidated Net Income (Quarter)	-1.12M	7.88M	0.08M	-15.74M	-7.42M	-72.88M	-10.32M	91.00M	-13.71M	-4.68M	-13.33M	-32.84M	-7.02M	-15.16M	-1.18M	11.98M				7.54M
Income towards Parent Company (Quarter)	-1.12M	7.88M	0.08M	-15.74M	-7.42M	-72.88M	-10.32M	91.00M	-13.71M	-4.68M	-13.33M	-32.84M	-7.02M	-15.16M	-1.18M	11.98M				7.54M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-1.12M	7.88M	0.08M	-15.74M	-7.42M	-72.88M	-10.32M	-49.19M	-13.71M	-10.20M	-15.80M	-36.38M	-3.20M	-20.72M	-1.70M	11.98M	-0.45M	-15.84M		7.54M
Additional items
EPS (Basic) (Quarter)	-0.03	0.20	0.00	-0.41	-0.18	-1.72	-0.24	2.15	-0.32	-0.23	-0.36	-0.33	-0.07	-0.12	-0.01	-0.24	-0.01	-0.33	0.01	0.24
EPS (Weighted Average and Diluted) (Quarter)	-0.03	0.19	0.00	-0.40		-1.72	-0.24	2.15	-0.32	-0.23	-0.67	-0.33	-0.22	-0.45	-0.04	0.52	-0.01	-0.33	0.01	0.23
Shares Outstanding (Weighted Average) (Quarter)			40.91M	38.50M		42.24M	42.38M	42.48M	43.03M	43.24M	43.35M	43.72M	45.43M	45.72M	46.18M	46.07M	47.13M	47.80M	47.62M	47.75M
Shares Outstanding (Diluted Average) (Quarter)		40.39M	43.30M	38.50M		42.46M	42.65M	43.07M	43.03M	43.24M	43.35M	43.72M	45.43M	46.00M	46.18M	46.07M	47.13M	47.80M	47.62M	48.65M
EBITDA (Quarter)	-0.98M	-4.55M	-11.16M	-18.46M	-7.97M	-76.56M	-11.74M	90.35M	-13.61M	-10.63M	-15.47M	17.53M	-3.29M	-1.31M	-0.42M	0.54M	-1.22M	-16.64M	-0.09M	1.35M
Interest Expenses (Quarter)			0.01M	1.20M				6.70M
Tax Rate (Quarter)		268.43%	101.61%	14.07%	7.47%	4.88%	5.49%	-0.33%	-0.68%	-0.04%	-0.73%	-1.55%	-0.53%	-0.02%	14.52%	5.12%	-3.23%	-0.80%	11.66%	-4.49%

Research Tools

Biolife Solutions Income Statement (2010-2025) | BLFS

Create an account

Sign In

Reset Password